Related Experiment Video
Updated: Jun 17, 2026
High-throughput DNA Extraction and Genotyping of 3dpf Zebrafish Larvae by Fin Clipping
Published on: June 29, 2018
Mild phenotype in Pelizaeus-Merzbacher disease caused by a PLP1-specific mutation
Hitoshi Osaka1, Shiro Koizume, Haruhiko Aoyama
1Division of Neurology, Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama 232-855, Japan. hosaka@kcmc.jp
Abstract:
We present the case of a 26 year-old man who developed normally until he began having difficulty walking at age 12. He subsequently became unable to stand at 15 years old and exhibited mental regression and generalized tonic convulsions by age 20. Magnetic resonance imaging revealed incomplete myelination of cerebral white matter, which resembled that of Pelizaeus-Merzbacher disease. By sequencing the proteolipid protein 1 (PLP1) gene, we found a novel mutation (c.352_353delAG (p.Gly130fs)) in the latter half of exon 3 (exon 3B) that is spliced out in the DM20 isoform. Exon 3B mutations are known to cause a mild phenotype since they do not disturb DM20 production. Mutations that truncate PLP1 correlate with a mild phenotype by activating the nonsense-mediated decay mechanism that specifically detects and degrades mRNAs containing a premature termination codon. This attenuates the production of toxic mutant PLP1. The very mild presentation in the present case seems to be derived from the unique nature of the mutation, which preserves DM20 production and decreases mutant PLP1.
Insights
A novel mutation in the proteolipid protein 1 (PLP1) gene was identified in a patient with symptoms resembling Pelizaeus-Merzbacher disease. This mutation preserves essential protein production, leading to a milder clinical presentation than typically observed.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Pelizaeus-Merzbacher disease (PMD) is a rare, inherited neurological disorder characterized by the under- or over-myelination of the central nervous system.
- Mutations in the proteolipid protein 1 (PLP1) gene are the primary cause of PMD, affecting the production of myelin in the brain.
- The PLP1 gene encodes the major structural protein of CNS myelin, crucial for proper nerve function.
Observation:
- A 26-year-old male presented with progressive motor and cognitive decline starting in adolescence, including difficulty walking, inability to stand, mental regression, and seizures.
- Cerebral MRI revealed incomplete myelination of white matter, consistent with PMD.
- Genetic analysis identified a novel mutation (c.352_353delAG (p.Gly130fs)) in exon 3B of the PLP1 gene.
Findings:
- The identified mutation is located in a region of exon 3B that is typically spliced out during the production of the DM20 isoform of PLP1.
- This specific mutation preserves DM20 isoform production, unlike other mutations that can lead to severe PMD phenotypes.
- The mutation likely activates nonsense-mediated decay, reducing the production of toxic mutant PLP1 and contributing to a milder clinical course.
Implications:
- This case highlights how specific mutations within the PLP1 gene can lead to variable phenotypes in PMD.
- Understanding the precise impact of mutations on protein isoforms and cellular degradation pathways is crucial for predicting disease severity.
- Further research into genotype-phenotype correlations in PLP1-related disorders can inform diagnostic and therapeutic strategies.
Related Concept Videos
01:33Pleiotropy
01:09Cytoskeletal Linker Proteins - Plakins
01:43Incomplete Dominance
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...